ABSTRACT
New scientific articles about tuberculosis (TB) are published daily worldwide. However, it is difficult for health care workers, overloaded with work, to stay abreast of the latest research findings and to discern which information can and should be used in their daily practice on assisting TB patients. The purpose of the III Brazilian Thoracic Association (BTA) Guidelines on TB is to critically review the most recent national and international scientific information on TB, presenting an updated text with the most current and useful tools against TB to health care workers in our country. The III BTA Guidelines on TB have been developed by the BTA Committee on TB and the TB Work Group, based on the text of the II BTA Guidelines on TB (2004). We reviewed the following databases: LILACS (SciELO) and PubMed (Medline). The level of evidence of the cited articles was determined, and 24 recommendations on TB have been evaluated, discussed by all of the members of the BTA Committee on TB and of the TB Work Group, and highlighted. The first version of the present Guidelines was posted on the BTA website and was available for public consultation for three weeks. Comments and critiques were evaluated. The level of scientific evidence of each reference was evaluated before its acceptance for use in the final text.
Subject(s)
Tuberculosis , Adult , Brazil , Child , Evidence-Based Medicine , Humans , Tuberculosis/diagnosis , Tuberculosis/therapyABSTRACT
Diariamente novos artigos científicos sobre tuberculose (TB) são publicados em todo mundo. No entanto, é difícil para o profissional sobrecarregado na rotina de trabalho acompanhar a literatura e discernir o que pode e deve ser aplicado na prática diária juntos aos pacientes com TB. A proposta das "III Diretrizes para TB da Sociedade Brasileira de Pneumologia e Tisiologia (SBPT)" é revisar de forma crítica o que existe de mais recente na literatura científica nacional e internacional sobre TB e apresentar aos profissionais da área de saúde as ferramentas mais atuais e úteis para o enfrentamento da TB no nosso país. As atuais "III Diretrizes para TB da SBPT" foram desenvolvidas pela Comissão de TB da SBPT e pelo Grupo de Trabalho para TB a partir do texto das "II Diretrizes para TB da SBPT" (2004). As bases de dados consultadas foram LILACS (SciELO) e PubMed (Medline). Os artigos citados foram avaliados para determinação do ...
New scientific articles about tuberculosis (TB) are published daily worldwide. However, it is difficult for health care workers, overloaded with work, to stay abreast of the latest research findings and to discern which information can and should be used in their daily practice on assisting TB patients. The purpose of the III Brazilian Thoracic Association (BTA) Guidelines on TB is to critically review the most recent national and international scientific information on TB, presenting an updated text with the most current and useful tools against TB to health care workers in our country. The III BTA Guidelines on TB have been developed by the BTA Committee on TB and the TB Work Group, based on the text of the II BTA Guidelines on TB (2004). We reviewed the following databases: LILACS (SciELO) and PubMed (Medline). The level of evidence of the cited articles was determined, and 24 recommendations ...
Subject(s)
Adult , Child , Humans , Tuberculosis , Brazil , Evidence-Based Medicine , Tuberculosis/diagnosis , Tuberculosis/therapyABSTRACT
To identify the clinical and epidemiological profile of cryptococcosis diagnosed at the University Hospital of the Federal University of Mato Grosso do Sul, Brazil, medical records of 123 patients admitted from January 1995 to December 2005 were analyzed. One hundred and four cases (84.5%) had HIV infection, six (4.9%) had other predisposing conditions and 13 (10.6%) were immunocompetent. Male patients predominated (68.3%) and their age ranged from 19 to 69 years (mean: 35.9). Most patients (73.2%) were born and lived lifelong in the state of Mato Grosso do Sul. Involvement of the central nervous system occurred in 103 patients (83.7%) and headache and vomiting were the most frequent symptoms. In 77 cases it was possible to identify the Cryptococcus species: 69 (89.6%) C. neoformans and eight (10.4%) C. gattii. Amphotericin B was the drug of choice for treatment (106/123), followed by fluconazole in 60% of cases. The overall lethality rate was 49.6%, being 51% among the HIV infected patients and 41.2% among the non-HIV infected (p > 0.05). Although cryptococcosis exhibited in our region a similar behavior to that described in the literature, the detection of an important rate of immunocompetent individuals and five C. gattii cryptococcosis in HIV-infected patients is noteworthy.
Subject(s)
AIDS-Related Opportunistic Infections/epidemiology , Cryptococcosis/epidemiology , AIDS-Related Opportunistic Infections/diagnosis , AIDS-Related Opportunistic Infections/drug therapy , Adult , Aged , Amphotericin B/therapeutic use , Antifungal Agents/therapeutic use , Brazil/epidemiology , Cryptococcosis/diagnosis , Cryptococcosis/drug therapy , Female , Fluconazole/therapeutic use , Humans , Male , Middle Aged , Retrospective StudiesABSTRACT
To identify the clinical and epidemiological profile of cryptococcosis diagnosed at the University Hospital of the Federal University of Mato Grosso do Sul, Brazil, medical records of 123 patients admitted from January 1995 to December 2005 were analyzed. One hundred and four cases (84.5 percent) had HIV infection, six (4.9 percent) had other predisposing conditions and 13 (10.6 percent) were immunocompetent. Male patients predominated (68.3 percent) and their age ranged from 19 to 69 years (mean: 35.9). Most patients (73.2 percent) were born and lived lifelong in the state of Mato Grosso do Sul. Involvement of the central nervous system occurred in 103 patients (83.7 percent) and headache and vomiting were the most frequent symptoms. In 77 cases it was possible to identify the Cryptococcus species: 69 (89.6 percent) C. neoformans and eight (10.4 percent) C. gattii. Amphotericin B was the drug of choice for treatment (106/123), followed by fluconazole in 60 percent of cases. The overall lethality rate was 49.6 percent, being 51 percent among the HIV infected patients and 41.2 percent among the non-HIV infected (p > 0.05). Although cryptococcosis exhibited in our region a similar behavior to that described in the literature, the detection of an important rate of immunocompetent individuals and five C. gattii cryptococcosis in HIV-infected patients is noteworthy.
O perfil clínico-epidemiológico de 123 casos de criptococose diagnosticados no Hospital Universitário da Universidade Federal de Mato Grosso do Sul, no período de janeiro de 1995 até dezembro de 2005, foi estudado retrospectivamente. Cento e quatro (84,9 por cento) casos tinham associação com HIV, seis (4,9 por cento) tinham outra condição predisponente e 13 (10,6 por cento) eram imunocompetentes. Houve predomínio do sexo masculino (68,3 por cento) e a idade variou de 19 a 69 anos (média de 35,9 anos). A maioria (73,2 por cento) era natural e procedente de Mato Grosso do Sul. O envolvimento do sistema nervoso central ocorreu em 103 (83,7 por cento) pacientes e os sintomas mais freqüentes foram cefaléia e vômitos. Em 77 casos foi possível identificar a espécie do agente, sendo 69 (89,6 por cento) C. neoformans e oito (10,4 por cento) C. gattii. O antifúngico mais utilizado foi anfotericina B (106/123) seguido de fluconazol em aproximadamente 60 por cento dos casos. A taxa de letalidade foi de 49,6 por cento, sendo 51 por cento entre os pacientes infectados pelo HIV e 41,2 por cento entre os não infectados pelo HIV (p > 0,005). Apesar da criptococose observada em nossa região apresentar comportamento semelhante ao descrito na literatura, chama a atenção a importante taxa da micose em imunocompetentes e cinco casos de infecção por C. gattii em pacientes HIV-positivos.
Subject(s)
Adult , Aged , Female , Humans , Male , Middle Aged , AIDS-Related Opportunistic Infections/epidemiology , Cryptococcosis/epidemiology , AIDS-Related Opportunistic Infections/diagnosis , AIDS-Related Opportunistic Infections/drug therapy , Amphotericin B/therapeutic use , Antifungal Agents/therapeutic use , Brazil/epidemiology , Cryptococcosis/diagnosis , Cryptococcosis/drug therapy , Fluconazole/therapeutic use , Retrospective StudiesABSTRACT
With the aim of measuring the prevalence of anti-parvovirus B19 IgG antibodies during pregnancy up to 24 weeks of gestation and detecting cases of nonimmune hydrops fetalis, 249 sera from pregnant women attending a reference hospital in Rio de Janeiro city, from June 2003 to November 2004 were collected. They were followed-up until the end of pregnancy, with 17 cases of fetal hydrops detected. Four cases were caused by parvovirus B19 and two of them occurred in pregnant women living in the western zone of the city, during February 2005. Anti-parvovirus B19 IgG antibodies were found in 172 (71.6%) pregnant women (CI 95% 65.5%-77.7%); this antibody prevalence is similar to results found for others Brazilian cities. The only variable associated with previous acquisition of IgG antibodies to parvovirus B19 was number of pregnancies greater than one (p= 0.02, CI 95% 0.36-0.94).
Subject(s)
Hydrops Fetalis/virology , Parvoviridae Infections/epidemiology , Parvovirus B19, Human/immunology , Pregnancy Complications, Infectious/virology , Adolescent , Adult , Antibodies, Viral/blood , Brazil/epidemiology , Female , Humans , Hydrops Fetalis/diagnosis , Hydrops Fetalis/epidemiology , Immunoglobulin G/blood , Middle Aged , Parvoviridae Infections/diagnosis , Pregnancy , Pregnancy Complications, Infectious/diagnosis , Pregnancy Complications, Infectious/epidemiology , Prevalence , Risk FactorsABSTRACT
Com o objetivo de medir a prevalência de anticorpos IgG contra o parvovírus B19 em gestantes com até 24 semanas de idade gestacional e detectar a ocorrência de casos de hidropisia fetal não-imune atribuídos a esse vírus, coletamos 249 amostras de soro em uma maternidade de referência na cidade do Rio de Janeiro, entre junho de 2003 e março de 2005. As gestantes foram acompanhadas até o termo da gestação, sendo detectados 17 casos de hidropisia fetal. Quatro casos foram atribuídos ao parvovírus B19 e dois destes ocorreram em gestantes residentes na zona oeste da cidade, em fevereiro de 2005. Resultados positivos para anticorpos IgG antiparvovírus B19 foram encontrados em 172 (71,6 por cento) gestantes (IC 95 por cento 65,5-77,7 por cento), sendo esta prevalência de anticorpos comparável à encontrada em outras cidades brasileiras. A única variável associada com aquisição prévia de anticorpos IgG foi número de gestações anteriores maior que um(p= 0,02, IC 95 por cento 0,36-0,94).
With the aim of measuring the prevalence of anti-parvovirus B19 IgG antibodies during pregnancy up to 24 weeks of gestation and detecting cases of nonimmune hydrops fetalis, 249 sera from pregnant women attending a reference hospital in Rio de Janeiro city, from June 2003 to November 2004 were collected. They were followed-up until the end of pregnancy, with 17 cases of fetal hydrops detected. Four cases were caused by parvovirus B19 and two of them occurred in pregnant women living in the western zone of the city, during February 2005. Anti-parvovirus B19 IgG antibodies were found in 172 (71.6 percent) pregnant women (CI 95 percent 65.5 percent-77.7 percent); this antibody prevalence is similar to results found for others Brazilian cities. The only variable associated with previous acquisition of IgG antibodies to parvovirus B19 was number of pregnancies greater than one (p= 0.02, CI 95 percent 0.36-0.94).
Subject(s)
Humans , Female , Pregnancy , Adolescent , Adult , Middle Aged , Hydrops Fetalis/virology , Parvoviridae Infections/epidemiology , /immunology , Pregnancy Complications, Infectious/virology , Antibodies, Viral/blood , Brazil/epidemiology , Hydrops Fetalis/diagnosis , Hydrops Fetalis/epidemiology , Immunoglobulin G/blood , Prevalence , Parvoviridae Infections/diagnosis , Pregnancy Complications, Infectious/diagnosis , Pregnancy Complications, Infectious/epidemiology , Risk FactorsABSTRACT
This prospective study, involving 76 pregnant women infected with HIV, paired with their 79 exposed infants, was carried out between May 1996 and October 2001, at the Reference Department for Pregnant Women Infected with HIV in Campo Grande, Mato Grosso do Sul. The mean age of the pregnant women was 24 years; 88% (67/76) apparently were infected due to sexual practices; 88% (67/76) were housewives; 823% (63/76) graduated from junior high school; 14.5% (11/76) reported co-infection with Hepatitis C, 9.2% with Syphilis; 51% (39/76) learned the diagnosis during prenatal care; 67% (51/76) reported HIV clinical symptomatology and 9.2% (7/76) reported opportunistic infections. Elective cesareans were performed in 57% (43/76). The mean gestational age at delivery was 38 weeks and we found 12.5% (10/80) pronatis; 97% (74/76) had a ruptured membrane time after less than four hours and one child (1.3%) was nursed. ACTG 076 Protocol (AIDS Clinical Trial Group 076) was used in 80% (61/76) of the pregnant women, with 100% adherence; 62% (38/61) used zidovudine plus another antiretroviral in the gestation; 92% (73/79) of the infants used zidovudine after the birth and 19% (14/73) used zidovudine and lamivudine. The transmission rate in this study was 2.5%.
Subject(s)
Anti-HIV Agents/therapeutic use , HIV Infections/transmission , Infectious Disease Transmission, Vertical/prevention & control , Pregnancy Complications, Infectious , Adolescent , Adult , Brazil/epidemiology , Cohort Studies , Enzyme-Linked Immunosorbent Assay , Female , Follow-Up Studies , HIV Infections/diagnosis , HIV Infections/prevention & control , Humans , Infant, Newborn , Lamivudine/therapeutic use , Pregnancy , Prospective Studies , Risk Factors , Viral Load , Zidovudine/therapeutic useABSTRACT
OBJETIVO: descrever a etiologia, evolução e prevalência de hidropisia fetal em coorte de gestantes em 10 anos de acompanhamento (1992 a 2002), em uma maternidade terciária. MÉTODOS: estudo retrospectivo foi realizado em pacientes referidas para a maternidade do Instituto Fernandes Figueira com o diagnóstico de hidropisia fetal, detectado pelo exame de ultra-sonografia, durante o período compreendido entre 1992 e 2002. Os casos foram selecionados quanto à etiologia (imune ou não-imune), sendo comparados quanto à evolução, procedimentos invasivos realizados e sobrevivência. A análise das variáveis foi realizada por meio do programa Epi-Info 6.0, sendo considerado valor de significância estatística um valor de p<0,05. RESULTADOS: durante o período de estudo, 80 gestantes foram atendidas com diagnóstico inicial de hidropisia fetal. A freqüência de hidropisia nesta população foi de 1 para 157 nascidos vivos. Isoimunização Rh (grupo imune - GI) foi diagnosticada em 13 casos (16,2 por cento), restando portanto 67 casos (83,8 por cento) considerados como devidos a causas não imunes (grupo não imune - GNI). As causas mais comuns de hidropisia fetal não imune são: idiopáticas (40,2 por cento), genéticas (20,8 por cento), infecciosas (20,7 por cento) e cardiopatia fetal (7,4 por cento). Foi encontrada diferença em relação à idade materna do grupo imune (média = 32,8 anos) quando comparada com o grupo não imune (média=28,7) (p=0,03), porém a idade gestacional ao nascimento foi similar em ambos os grupo, (média de 33,6 semanas no grupo imune e de 33,1 semanas no grupo não imune (p=0,66). Amniocentese e transfusão sanguínea in utero foram realizadas com maior freqüência no grupo imune (p<0,001) e a letalidade perinatal encontrada foi de 53,8 por cento no grupo imune e 68,6 por cento no grupo não imune (p=0,47). A pesquisa complementar de anticorpos IgG anti-parvovírus B19 foi realizada em 41 dos 67 casos de hidropisia fetal não imune e somente 16 apresentaram resultado pos...
Subject(s)
Female , Pregnancy , Humans , Incidence , Parvovirus B19, Human , Pregnancy Complications, Infectious , Hydrops Fetalis/etiology , Retrospective Studies , Pregnancy, High-Risk , Rh Isoimmunization , PrognosisABSTRACT
This prospective study, involving 76 pregnant women infected with HIV, paired with their 79 exposed infants, was carried out between May 1996 and October 2001, at the Reference Department for Pregnant Women Infected with HIV in Campo Grande, Mato Grosso do Sul. The mean age of the pregnant women was 24 years; 88 percent (67/76) apparently were infected due to sexual practices; 88 percent (67/76) were housewives; 823 percent (63/76) graduated from junior high school; 14.5 percent (11/76) reported co-infection with Hepatitis C, 9.2 percent with Syphilis; 51 percent (39/76) learned the diagnosis during prenatal care; 67 percent (51/76) reported HIV clinical symptomatology and 9.2 percent (7/76) reported opportunistic infections. Elective cesareans were performed in 57 percent (43/76). The mean gestational age at delivery was 38 weeks and we found 12.5 percent (10/80) pronatis; 97 percent (74/76) had a ruptured membrane time after less than four hours and one child (1.3 percent) was nursed. ACTG 076 Protocol (AIDS Clinical Trial Group 076) was used in 80 percent (61/76) of the pregnant women, with 100 percent adherence; 62 percent (38/61) used zidovudine plus another antiretroviral in the gestation; 92 percent (73/79) of the infants used zidovudine after the birth and 19 percent (14/73) used zidovudine and lamivudine. The transmission rate in this study was 2.5 percent.
Subject(s)
Adolescent , Adult , Female , Humans , Infant, Newborn , Pregnancy , Anti-HIV Agents/therapeutic use , HIV Infections/transmission , Infectious Disease Transmission, Vertical , Pregnancy Complications, Infectious , Brazil/epidemiology , Cohort Studies , Enzyme-Linked Immunosorbent Assay , Follow-Up Studies , HIV Infections/diagnosis , HIV Infections/prevention & control , Lamivudine/therapeutic use , Prospective Studies , Risk Factors , Viral Load , Zidovudine/therapeutic useABSTRACT
The polymerase chain reaction amplification of a fragment of the B1 gene of Toxoplasma gondii coupled to hybridization was performed in 42 patients from Rio de Janeiro, Brazil. The results showed 50% of positivity in the IgM positive toxoplasmosis group, and 12.5% in the positive IgG and negative IgM individuals. The data presented here revealed a lack of specificity of the molecular approach, clearly indicating that the primers used may co-amplify human sequences.
Subject(s)
Polymerase Chain Reaction/standards , Toxoplasma/genetics , Toxoplasmosis/diagnosis , Animals , Gene Amplification , Genes, Protozoan/genetics , Immunoglobulin G/analysis , Immunoglobulin M/analysis , Mice , Sensitivity and SpecificityABSTRACT
In the past two decades, major improvements in blood safety have been achieved, particularly for HIV and hepatitis C virus (HCV). A prospective study was carried out between 1996 and 1999 in Brazil to determine the incidence of post-transfusion infection in surgery patients caused by HCV. One hundred sixty-four patients who received a blood transfusion during cardiac surgery were followed for six months and blood samples collected before and after surgery were assessed to investigate HCV infection. Alanine aminotransferase levels were serially determined, as well as clinical data related to hepatitis. Prior to surgery, HCV infection was detected by anti-HCV ELISA III in 6 patients. Any post-surgical samples which were positive by a third generation ELISA test were confirmed by immunoblot and reverse-transcription polymerase chain reaction (RT-PCR), as were the pre-transfusion samples to exclude pre-transfusion HCV infection not detected by ELISA screening. Results indicated that one patient who was previously considered negative for HCV antibody in the pre-surgical sample was later found to be positive for HCV by RT-PCR in that sample. Seroconversion for HCV antibody after surgery was observed in two patients, one of them with clinical hepatitis; their genotypes were 1a and 1b. The overall prevalence of HCV infection was 4.26% (7/164) and the incidence rate of HCV infection after surgery was 1.27% (2/157). This study shows a high rate of HCV infection acquired post-transfusion in a cohort of surgery patients in Brazil and suggests that better screening methods such as viral RNA assessment may be effective in lowering this rate.
Subject(s)
Cardiac Surgical Procedures , Hepatitis C/etiology , Transfusion Reaction , Brazil/epidemiology , Hepatitis C/diagnosis , Hepatitis C/epidemiology , Hepatitis C Antibodies/blood , Humans , Incidence , Prospective Studies , RNA, Viral/bloodABSTRACT
This report describes a case of Toxoplasma encephalitis during pregnancy of an HIV infected woman who was severely immunosuppressed (CD(4): 17 cells/mm3), had a high viral load (RNA PCR:230,000 copies/ml), was treated with sulfadiazine, pyrimethamine and folinic acid for toxoplasmosis and was being treated with highly potent antiretroviral drugs (AZT, 3TC and nelfinavir) for HIV infection. The newborn was born through an elective C-section, received six weeks of AZT according to the 076 protocol and was clinically normal at birth. Subsequently he had two RNA PCR negatives for HIV, seroreverted and had no clinical or laboratory evidence of congenital toxoplasmosis. Despite the concerns of the use of these combined therapies on the foetus during pregnancy, their efficacy illustrates that keeping the mother alive and in good health is an important strategy to protect the unborn child from acquiring these two infections.
Subject(s)
AIDS-Related Opportunistic Infections/drug therapy , AIDS-Related Opportunistic Infections/parasitology , HIV Infections/complications , HIV Infections/transmission , Infectious Disease Transmission, Vertical , Toxoplasmosis, Cerebral/complications , Toxoplasmosis, Cerebral/drug therapy , AIDS-Related Opportunistic Infections/transmission , Adult , Animals , Anti-HIV Agents/therapeutic use , Antiretroviral Therapy, Highly Active , Female , HIV/isolation & purification , HIV Infections/drug therapy , HIV Infections/virology , Humans , Infant, Newborn , Infant, Newborn, Diseases/drug therapy , Infant, Newborn, Diseases/parasitology , Infant, Newborn, Diseases/virology , Infectious Disease Transmission, Vertical/prevention & control , Pregnancy , Pregnancy Complications, Infectious/drug therapy , Pregnancy Complications, Infectious/parasitology , Pregnancy Complications, Infectious/virology , Toxoplasma/isolation & purification , Toxoplasmosis, Cerebral/transmission , Treatment Outcome , Viral LoadABSTRACT
This report describes a case of Toxoplasma encephalitis during pregnancy of an HIV infected woman who was severely immunosuppressed (CD(4): 17 cells/mm3), had a high viral load (RNA PCR:230,000 copies/ml), was treated with sulfadiazine, pyrimethamine and folinic acid for toxoplasmosis and was being treated with highly potent antiretroviral drugs (AZT, 3TC and nelfinavir) for HIV infection. The newborn was born through an elective C-section, received six weeks of AZT according to the 076 protocol and was clinically normal at birth. Subsequently he had two RNA PCR negatives for HIV, seroreverted and had no clinical or laboratory evidence of congenital toxoplasmosis. Despite the concerns of the use of these combined therapies on the foetus during pregnancy, their efficacy illustrates that keeping the mother alive and in good health is an important strategy to protect the unborn child from acquiring these two infections.
Subject(s)
Adult , Animals , Female , Humans , Infant, Newborn , Pregnancy , AIDS-Related Opportunistic Infections/drug therapy , AIDS-Related Opportunistic Infections/parasitology , HIV Infections/complications , HIV Infections/transmission , Infectious Disease Transmission, Vertical , Toxoplasmosis, Cerebral , Anti-HIV Agents , Antiretroviral Therapy, Highly Active , Pregnancy Complications, Infectious/drug therapy , Pregnancy Complications, Infectious/parasitology , Pregnancy Complications, Infectious/virology , Infant, Newborn, Diseases/drug therapy , Infant, Newborn, Diseases/parasitology , Infant, Newborn, Diseases/virology , HIV , AIDS-Related Opportunistic Infections/transmission , HIV Infections/drug therapy , HIV Infections/virology , Infectious Disease Transmission, Vertical , Toxoplasma , Toxoplasmosis, Cerebral , Treatment Outcome , Viral LoadABSTRACT
Objectives: To determine the HIV vertical transmission rate (VTR) and associated risk factors by use of zidovudine and infant care education in Brazil. Methods: Since 1995, a prospective cohort of HIV infected pregnant womwn has been followed at the Federal University of Rio de Janeiro. A multidisciplinary team was established to implement the best available strategy to prevent maternal-infant HIV transmission. Patients with AIDS or low CD4 and high viral load received anti-retroviral drugs in addition to zidovudine. Children were considered infected if they had 2 positive PCR-RNA test between 1 and 4 months of age, or were HIV antibody positive after 18 months. Education regarding infant treatment and use of formula insteadof breast feeding was provided. Results: Between 199 and August, 2000. HIV status was determined for 145 infants. Compliance with intra-partum treatment, infant treatment and use of formula was 88.2 percent. Intra-partum zidovudine treatment was completed in 134/145 (92.6 percent) of patients; 88.1 percent had rupture of membranes < 4 hours; 85.4 percent of mothers were asymptomatic. The mean CD4 count was 428,4 cells and mean viral load 39,050 copies. HIV vertical transmission rate was 4/145 (2.75 percent; CI: 0.1 percent - 5.4 percent). The only risk factor significantly associated with transmission was a failure to use zidovudine intra-partum in 2 of the 4 mothers (50 percent versus 6.4 percent in non-transmitting mothers). A trend toward low CD4 and high viral load at entry, and rupture of membranes > 4 hours were associated with increased HIV transmission. Conclusion: HIV vertical transmission in Brazil was reduced to a level similar to other countries with the most effective prevention programs using a multidisciplinary team approach. A high levelof compliance for use of anti-retroviral drugs, the provision of health education to mothers, and use of formula for all exposed infants.
Subject(s)
Humans , Female , Infant, Newborn , Pregnancy , HIV-1 , Infectious Disease Transmission, Vertical , Patient Care Team , Acquired Immunodeficiency Syndrome/prevention & control , Acquired Immunodeficiency Syndrome/therapy , Acquired Immunodeficiency Syndrome/transmission , Zidovudine , Health Education , Maternal and Child Health , Risk Factors , Viral LoadABSTRACT
Procurou conhecer o perfil social e cultural relacionado a risco de infecçäo pelo HIV em mulheres, descrevendo algumas variáveis epidemiológicas e revelando relatos de risco, o significado de sua vivência com AIDS e assistência recebida. Através de um questionário semi-estruturado, entrevistou-se 25 mulheres internadas no Hospital Universitário da UFRJ, no período anterior à disponibilizaçäo das drogas combinadas. A maioria referiu baixa escolaridade, ocupaçöes de baixa qualificaçäo ou eram donas de casa, sendo sua renda familiar, em alguns casos, pior que a média dos usuários deste hospital. A representaçäo predominante sobre risco associava a AIDS a uma "doença do outro" e DSTs eram percebidas como infecçöes masculinas, embora várias relatassem episódios destas, anteriormente ao HIV. Elas tiveram seu diagnóstico/tratamento só após o adoecimento ou morte do companheiro e ou filho. O estudo sugere estratégias preventivas que, prioritariamente, reforçam o poder de negociaçäo sexual destas mulheres silenciosas e atuam sobre os homens, como participantes potencialmente ativos nos programas de saúde reprodutiva, os quais incorporam a questäo DST/AIDS.
Subject(s)
Humans , Female , Acquired Immunodeficiency Syndrome/epidemiology , InpatientsABSTRACT
Säo revistos 38 casos de paracoccidioidomicose (PCM) em crianças entre três e 14 anos de idade, internadas em três instituiçöes da cidade do Rio de Janeiro (1981 a 1996). Seus hemogramas foram estudados visando fundamentalmente a contagem dos eosinófilos, taxas de hematócritos e de VHS na 1ª hora. Faz-se o estudo específico da série sobre o comportamento dos eosinófilos em sangue periférico, em um, dois ou mais hemogramas de maior expressäo. Vinte e três crianças tiveram contagens absolutas de eosinófilos acima de 500/mmü, nove acima de 3.000/mmü e sete acima de 5.000/mmü. As observaçöes das nove crianças que tiveram mais de 3.000 eosinófilos/mmü säo apresentadas com a finalidade de ampliar as informaçöes da história natural da PCM nestas faixas etárias. As eosinofilias e hipereosinofilias vistas foram transitórias, às vezes flutuantes, nunca persistentes, desapareceram espontaneamente ou após a terapêutica antifúngica e, em duas crianças, surgiram, durante a mesma. Taxas de eosinófilos muito elevadas trouxeram à baila diagnósticos diferenciais com outras causas de hipereosinofilias, particularmente parasitoses intestinais, larva migrans visceral, esquistossomose aguda, leucemia eosinofílica, síndrome hipereosinofílico e outras condiçöes. Provavelmente as taxas elevadas de eosinófilos nesta micose representem mecanismos de defesa näo muito aperfeiçoados. Säo revistos alguns dados referentes à origem das eosinofilias, assim como o papel dos eosinófilos nestas situaçöes.